Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia (EPICOR ASIA)

June 13, 2014 updated by: AstraZeneca

Long-Term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Asia

The purpose of this study is to describe the short-and long-tern (i.e. up to 2 years following the index event) AMPs in patients hospitalized for an acute coronary syndrome (i.e. STEMI or NSTE-ACS), and to document clinical outcomes, economic aspects and impact on quality of life of these AMPs in a 'real-life' setting.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

13011

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
      • HongKong, China
        • Research Site
      • Ningxia, China
        • Research Site
      • Qingdao, China
        • Research Site
    • Anhui
      • Hefei, Anhui, China
        • Research Site
      • Wuhu, Anhui, China
        • Research Site
    • Beijing
      • Beijing, Beijing, China
        • Research Site
    • Chongqing
      • Chongqing, Chongqing, China
        • Research Site
    • Fujian
      • Fuzhou, Fujian, China
        • Research Site
    • Gansu
      • Lanzhou, Gansu, China
        • Research Site
    • Guangdong
      • Foshan, Guangdong, China
        • Research Site
      • Guangzhou, Guangdong, China
        • Research Site
      • Shenzhen, Guangdong, China
        • Research Site
    • Guangxi
      • Nanning, Guangxi, China
        • Research Site
      • Yulin, Guangxi, China
        • Research Site
    • Guizhou
      • Guiyang, Guizhou, China
        • Research Site
    • Hebei
      • Baoding, Hebei, China
        • Research Site
      • Shijiazhuang, Hebei, China
        • Research Site
      • Tangshan, Hebei, China
        • Research Site
    • Heilongjiang
      • Daqing, Heilongjiang, China
        • Research Site
      • Harbin, Heilongjiang, China
        • Research Site
    • Henan
      • Zhengzhou, Henan, China
        • Research Site
    • Hubei
      • Shiyan, Hubei, China
        • Research Site
      • Wuhan, Hubei, China
        • Research Site
    • Hunan
      • Changsha, Hunan, China
        • Research Site
    • Jiangsu
      • Nanjing, Jiangsu, China
        • Research Site
      • Wuxi, Jiangsu, China
        • Research Site
      • Xuzhou, Jiangsu, China
        • Research Site
      • Zhenjiang, Jiangsu, China
        • Research Site
    • Jilin
      • Changchun, Jilin, China
        • Research Site
    • Liaoning
      • Jinzhou, Liaoning, China
        • Research Site
      • Shenyang, Liaoning, China
        • Research Site
      • Yingkou, Liaoning, China
        • Research Site
    • Qinghai
      • Xining, Qinghai, China
        • Research Site
    • Shaanxi
      • Xi'an, Shaanxi, China
        • Research Site
    • Shandong
      • Jinan, Shandong, China
        • Research Site
    • Shanghai
      • Shanghai, Shanghai, China
        • Research Site
    • Shanxi
      • Changzhi, Shanxi, China
        • Research Site
      • Jinzhong, Shanxi, China
        • Research Site
      • Taiyuan, Shanxi, China
        • Research Site
    • Sichuan
      • Chengdu, Sichuan, China
        • Research Site
    • Tianjin
      • Tianjin, Tianjin, China
        • Research Site
    • Xinjiang
      • Shihezi, Xinjiang, China
        • Research Site
      • Urumuqi, Xinjiang, China
        • Research Site
    • Yunnan
      • Kunming, Yunnan, China
        • Research Site
    • Zhejiang
      • Hangzhou, Zhejiang, China
        • Research Site
  • India
      • Delhi, India
        • Research Site
    • Andhra Pradesh
      • Hyderabad, Andhra Pradesh, India
        • Research Site
    • Assam
      • Guwahati, Assam, India
        • Research Site
    • Gujarat
      • Ahmedabad, Gujarat, India
        • Research Site
      • Baroda, Gujarat, India
        • Research Site
      • Surat, Gujarat, India
        • Research Site
    • Haryana
      • Gurgaon, Haryana, India
        • Research Site
    • Karnataka
      • Bangalore, Karnataka, India
        • Research Site
      • Manipal, Karnataka, India
        • Research Site
    • Kerala
      • Kochi, Kerala, India
        • Research Site
      • Trivandrum, Kerala, India
        • Research Site
    • Madhya Pradesh
      • Bhopal, Madhya Pradesh, India
        • Research Site
      • Bilaspur, Madhya Pradesh, India
        • Research Site
    • Maharashtra
      • Aurangabad, Maharashtra, India
        • Research Site
      • Mumbai, Maharashtra, India
        • Research Site
      • Nagpur, Maharashtra, India
        • Research Site
      • Pune, Maharashtra, India
        • Research Site
    • Punjab
      • Ludhiana, Punjab, India
        • Research Site
      • Mohali, Punjab, India
        • Research Site
    • Rajasthan
      • Ajmer, Rajasthan, India
        • Research Site
      • Jaipur, Rajasthan, India
        • Research Site
    • Tamil Nadu
      • Chennai, Tamil Nadu, India
        • Research Site
      • Coimbatore, Tamil Nadu, India
        • Research Site
      • Madurai, Tamil Nadu, India
        • Research Site
    • Uttar Pradesh
      • Lucknow, Uttar Pradesh, India
        • Research Site
    • West Bengal
      • Kolkata, West Bengal, India
        • Research Site
  • Korea, Republic of
      • Busan, Korea, Republic of
        • Research Site
      • Chuncheon, Korea, Republic of
        • Research Site
      • Deagu, Korea, Republic of
        • Research Site
      • Gwangju, Korea, Republic of
        • Research Site
      • Jeju, Korea, Republic of
        • Research Site
      • Pusan, Korea, Republic of
        • Research Site
      • Seoul, Korea, Republic of
        • Research Site
    • Chungcheongnam-do
      • Cheonan, Chungcheongnam-do, Korea, Republic of
        • Research Site
    • Gyeonggi-do
      • Bucheon, Gyeonggi-do, Korea, Republic of
        • Research Site
      • Goyang-si, Gyeonggi-do, Korea, Republic of
        • Research Site
      • Suwon, Gyeonggi-do, Korea, Republic of
        • Research Site
    • Gyeongsangnamdo
      • Yangsan, Gyeongsangnamdo, Korea, Republic of
        • Research Site
    • Jeollabuk-do
      • IKsan, Jeollabuk-do, Korea, Republic of
        • Research Site
  • Malaysia
      • Penang, Malaysia
        • Research Site
    • Kuching
      • Sarawak, Kuching, Malaysia
        • Research Site
  • Singapore
      • Singapore, Singapore
        • Research Site
  • Thailand
    • Bangkok
      • Bangkoknoi, Bangkok, Thailand
        • Research Site
      • Huaykwang, Bangkok, Thailand
        • Research Site
      • PathumWan, Bangkok, Thailand
        • Research Site
      • Payathai, Bangkok, Thailand
        • Research Site
      • Rachathevi, Bangkok, Thailand
        • Research Site
      • Saimai, Bangkok, Thailand
        • Research Site
    • Chanthaburi
      • Muang, Chanthaburi, Thailand
        • Research Site
    • Chiangmai
      • Muang, Chiangmai, Thailand
        • Research Site
    • Chiangrai
      • Muang, Chiangrai, Thailand
        • Research Site
    • Chonburi
      • Muang, Chonburi, Thailand
        • Research Site
    • Khonkaen
      • Muang, Khonkaen, Thailand
        • Research Site
    • Lampang
      • Muang, Lampang, Thailand
        • Research Site
    • Nakornratchaseema
      • Muang, Nakornratchaseema, Thailand
        • Research Site
    • Nan
      • Muang, Nan, Thailand
        • Research Site
    • Pathumthani
      • Klongluang, Pathumthani, Thailand
        • Research Site
    • Phitsanulok
      • Muang, Phitsanulok, Thailand
        • Research Site
    • Songkla
      • Muang, Songkla, Thailand
        • Research Site
    • Suphanburi
      • Muang, Suphanburi, Thailand
        • Research Site
    • Surat Thani
      • Muang, Surat Thani, Thailand
        • Research Site
    • Udonthani
      • Muang, Udonthani, Thailand
        • Research Site
  • Vietnam
      • Ho Chi Minh City, Vietnam
        • Research Site
      • Hue, Vietnam
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Asian patients hospitalized for ACS within 48 hours of symptom onset and who have a final diagnosis of unstable angina (UA), STEMI or non-ST-segment elevation myocardial infarction (NSTEMI).

Description

Inclusion Criteria:

  • Written informed consent has been provided.
  • Diagnosis of STEMI, NSTEMI or UA
  • Hospitalization for the first time within 48 hours of onset of symptoms.

Exclusion Criteria:

  • UA, STEMI, NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or post-PCI UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons.
  • Current participation in a randomised interventional clinical trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
1

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
short- and long-term medication and treatment prescribed by physicians in real-life setting
Time Frame: up to 3 years
up to 3 years

Secondary Outcome Measures

Outcome Measure
Time Frame
clinical outcome (Cardiovascular events)
Time Frame: up to 3 years
up to 3 years
cost of hospitalization
Time Frame: up to 3 years
up to 3 years
quality of life (EQ-5D questionnaire)
Time Frame: up to 3 years
up to 3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Investigators

  • Study Director: Guy Yeoman, AstraZeneca
  • Study Chair: Prof. Huo Yong, Peking University 1st Hospital
  • Study Chair: Jayanti Visvanathan, AstraZeneca

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2011

Primary Completion (Actual)

May 1, 2014

Study Completion (Actual)

May 1, 2014

Study Registration Dates

First Submitted

May 23, 2011

First Submitted That Met QC Criteria

May 25, 2011

First Posted (Estimate)

May 26, 2011

Study Record Updates

Last Update Posted (Estimate)

June 16, 2014

Last Update Submitted That Met QC Criteria

June 13, 2014

Last Verified

June 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIS-CAP-XXX-2011/1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Coronary Syndrome

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe